The PCB’s scientific community joins the fight against SARS-CoV-2 Blog Post

In response to the health emergency caused by SARS-CoV-2, research centres and biotech companies in the Barcelona Science Park (Parc Científic de Barcelona, PCB) are leading scientific progress in the treatment, vaccination and diagnosis of the novel coronavirus. The PCB will ensure that public centres and businesses can continue with their research projects by providing the resources and services they need.

 

The European project GLAM develops a multiplexed biosensor for personalized diagnosis and therapy for bladder cancers Blog Post

A European consortium led by Centre Tecnològic Leitat –through its Biomed Division in the Barcelona Science Park (PCB)– has finished the GLAM project, the aim of which was to develop a photonic biosensor for a non-invasive diagnosis and personalized therapy for bladder cancers. The project involved the participation of 10 European organizations with resources and capabilities from the academia and scientific and business field, among them the Institute for Bioengineering of Catalonia (IBEC), which is also located in PCB.

 

GlyCardial Diagnostics wins the EmprendedorXXI 2019 Award in the ‘Health Tech’ category Blog Post

GlyCardial Diagnostics has won the  the EmprendedorXXI Award in the ‘Health Tech’ category, one of the six awards granted in its twelfth year to recognize those companies in Spain and Portugal with greatest growth potential in several sectors linked to the new innovation trends. The winners have been selected from 961 companies in Spain and Portugal. The biotechnology company, headquartered in the Barcelona Science Park, adds this award to the EmprendedorXXI Award in Catalonia, which it received on 9 May.

 

Whole Genix receives the 2019 ‘Medicina Siglo XXI’ Award for Medical Innovation Blog Post

The company Whole Genix, based in the Barcelona Science Park, received the 2019 ‘Medicina Siglo XXI’ Award in the Medical Innovation category during the gala marking the II edition of these prizes, held on Friday in Hotel Arts in Barcelona. With these awards, the editorial group El Suplemento aims to value the professional, scientific and innovative talent of professionals who work for and for health in various specialties and from different Spanish cities.

 

IBEC, ISGlobal and Bioiberica join forces to study new strategies based on nanomedicine to combat malaria Blog Post

The Institute for Bioengineering of Catalonia (IBEC), the Barcelona Institute for Global Health (ISGlobal) and the biotech firm Bioiberica have signed a partnership agreement to study the development of new compounds derived from heparin to combat malaria. The partnership, which was officially announced this morning at the international Biospain meeting held in Bilbao.

 

UL Acquires AWS Truepower to expand global renewable energy portfolio Blog Post

UL (Underwriters Laboratories), a global safety science leader, announces the acquisition of  AWS Truepower, a leading energy engineering services and advisory firm. This achievement expands UL’s global renewable energy portfolio by strengthening full lifecycle solutions for wind and solar energy sectors. AWS Truepower operates in Europe and Latin America through AWS Truepower SLU, a spanish company located at the Barcelona Scientific Park (PCB).

 

A scientific study outlines the evolution of genes involved in selenoprotein synthesis Blog Post

An international study has been highlighted on the cover of the prestigious journal Genome Research. It illustrates the evolution of selenophosphate synthetase genes —involved in selenoprotein synthesis— in prokaryotic and eukaryotic organisms. Montserrat Corominas and Florenci Serras, professors in the Department of Genetics and researchers at the Institute of Biomedicine of the University of Barcelona (IBUB) at PCB, participate in the study together with the scientific team led by Roderic Guigó, expert at the Centre for Genomic Regulation (CRG-UPF).

 

Leitat leads GLAM, a European project to improve cancer diagnosis Blog Post

A European consortium led by Centre Tecnològic Leitat –through its Biomed Divisionlocated at the Barcelona Science Park (PCB)– has started the Glass-Laser Multiplexed Biosensor (GLAM) project, the aim of which is to develop a photonic-based point-of-care device for a non-invasive diagnosis of Genitourinary Cancer (GU). The GLAM project which will expand for 4 years will involve the participation of 10 European organizations with resources and capabilities from the academia and scientific and business field, among them the Institute for Bioengineering of Catalonia (IBEC), located at PCB. 

 

More than 50 attendees in the Crea!Empresa conference Blog Post

The Bosch i Gimpera Foundation (FBG) organized last November 13 the 7th edition of the Crea!Empresa Conference at the Barcelona Science Park, which aim is to promote entrepreneurship. A total of 57 people attended the conference. The attendees were mainly students, graduates or doctorates (66,7%) and almost 40% were from the Biology Faculty (38 %). This conference wants to promote entrepreneurship in the university community and to make known new careers in research, such as entrepreneurship.